Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Q4 2022 vs. Q3 2022
How the institutions holding Biofrontera Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 16 | 14 | −2 |
| Shares | 853.8K | 795.6K | −58.2K (−6.8%) |
| Value | $900.0K | $729.4K | −$170.6K (−19.0%) |
New holders (2)
Institutions that held Biofrontera Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Quent Capital, LLC | 1,787 | $1.64K | 0.00% |
| Bank of America Corp | 36 | $32 | 0.00% |
Sold out (4)
Institutions that held Biofrontera Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Bank of Montreal | 15,000 | $19.0K |
| UBS Group AG | 4,740 | $5.00K |
| Morgan Stanley | 14 | $0 |
| Royal Bank of Canada | 106 | $0 |